Aphexda Injection, Powder, Lyophilized, For Solution
Product Images NDC 73441-062

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Aphexda (NDC 73441-062). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gamida Cell Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Aphexda 01)

Chemical Structure (Aphexda 01)
Chemical structure of Motixafortide, the active ingredient in APHEXDA. The diagram shows the peptide sequence with amino acid residues annotated, illustrating its molecular composition.*
FDA Label Image

Chemical Structure (Aphexda 02)

Chemical Structure (Aphexda 02)
Chemical structure of motixafortide, depicting its molecular bonds and atoms in a skeletal formula format.*
FDA Label Image

Chemical Structure (Aphexda 03)

Chemical Structure (Aphexda 03)
Chemical structure diagram of Motixafortide, the active ingredient in APHEXDA injection, powder, lyophilized, for solution. The structure shows the molecular arrangement including a naphthalene ring and a carboxamide group.*
FDA Label Image

Chemical Structure (Aphexda 04)

Chemical Structure (Aphexda 04)
Chemical structure of motixafortide, the active ingredient in APHEXDA injection, powder, lyophilized, for solution. The structure shows a fluorophenyl group attached to a cyclohexane carboxylic acid moiety.*
FDA Label Image

Principal Display Panel (62 mg Vial Carton)

Principal Display Panel (62 mg Vial Carton)
Packaging label for APHEXDA injection powder, lyophilized, for solution, 62 mg per vial. The label includes the proprietary name APHEXDA and the generic name motixafortide, indicating subcutaneous use. It notes storage instructions, manufacturer information (Ayrmid Pharma Ltd. for Gamida Cell Inc.), and dosage guidance. The NDC 73441-062-01, barcode, and other identifying marks are visible on the carton's sides.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.